RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 137 filers reported holding RIGEL PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 6.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $22,000 | -98.2% | 13,809 | -97.6% | 0.00% | -91.2% |
| Q4 2019 | $1,227,000 | +19.1% | 573,472 | +4.1% | 0.03% | +36.0% |
| Q3 2019 | $1,030,000 | +99.6% | 550,893 | +178.9% | 0.02% | +127.3% |
| Q2 2019 | $516,000 | +1463.6% | 197,533 | +1332.0% | 0.01% | +1000.0% |
| Q4 2016 | $33,000 | -94.1% | 13,794 | -91.0% | 0.00% | -94.1% |
| Q3 2016 | $563,000 | +117.4% | 153,311 | +46.3% | 0.02% | +112.5% |
| Q3 2015 | $259,000 | -74.3% | 104,795 | -66.6% | 0.01% | -70.4% |
| Q2 2015 | $1,007,000 | -56.8% | 313,784 | -52.0% | 0.03% | -54.2% |
| Q1 2015 | $2,331,000 | +447.2% | 653,040 | +251.7% | 0.06% | +555.6% |
| Q4 2014 | $426,000 | +95.4% | 185,667 | +230.6% | 0.01% | +50.0% |
| Q1 2014 | $218,000 | – | 56,163 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 8,350,000 | $28,557,000 | 5.86% |
| Ion Asset Management Ltd. | 3,632,132 | $12,422,000 | 1.43% |
| CM Management, LLC | 500,000 | $1,710,000 | 1.27% |
| SECTOR GAMMA AS | 1,530,490 | $5,234,000 | 0.96% |
| Rhenman & Partners Asset Management AB | 1,520,000 | $5,198,000 | 0.36% |
| Rock Springs Capital Management LP | 4,742,000 | $16,218,000 | 0.35% |
| Telemetry Investments, L.L.C. | 90,000 | $308,000 | 0.35% |
| DAFNA Capital Management LLC | 275,500 | $942,000 | 0.22% |
| KELLEHER FINANCIAL ADVISORS | 100,000 | $342,000 | 0.22% |
| Virtus ETF Advisers LLC | 91,971 | $315,000 | 0.13% |